LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
48.88
+0.63 (1.30%)
Feb 5, 2025, 11:42 AM EST - Market open
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.65 billion as of February 5, 2025. Its market cap has decreased by -1.41% in one year.
Market Cap
2.65B
Enterprise Value
2.95B
1-Year Change
-1.41%
Ranking
Category
Stock Price
$48.88
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.65B, a decrease of -22.29%. That is a compound annual growth rate of -2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 2.61B | 3.78% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.74B |
| UnitedHealth Group | 504.48B |
| Novo Nordisk | 367.70B |
| Johnson & Johnson | 365.65B |
| AbbVie | 336.00B |
| Merck & Co. | 252.43B |
| Thermo Fisher Scientific | 227.11B |
| Abbott Laboratories | 222.79B |